Click on the company for more information on the subsidy award. Click on the parent name to reach the summary page for that parent company.
Company | Parent | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
---|---|---|---|---|---|---|---|
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $903,866 | tax credit/rebate | |
ImClone Systems LLC | Eli Lilly | New York | state | 2012 | $901,984 | enterprise zone | |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $900,091 | tax credit/rebate | |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2015 | $900,000 | tax credit/rebate | |
Boehringer Ingelheim Fremont Inc | Boehringer Ingelheim | California | state | 2021 | $898,743 | training reimbursement | |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2018 | $895,622 | tax credit/rebate | |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2020 | $894,247 | tax credit/rebate | |
Novartis Animal Health US, Inc. | Eli Lilly | North Carolina | state | 2015 | $885,684 | tax credit/rebate | |
Eisai, Inc. | Eisai | North Carolina | state | 2015 | $881,846 | tax credit/rebate | |
Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals | Massachusetts | state | 2012 | $880,128 | tax credit/rebate | |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2008 | $879,466 | tax credit/rebate | |
RegeneronN | Regeneron Pharmaceuticals | New York | local | 2020 | $878,388 | tax credit/rebate | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2009 | $877,386 | enterprise zone | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2009 | $877,386 | enterprise zone | |
Merck & Co., Inc. | Merck | New Jersey | state | 1999 | $874,000 | grant | |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2016 | $868,373 | property tax abatement | |
Pfizer, Inc. | Pfizer | New York | local | 2008 | $862,541 | tax credit/rebate; property tax abatement | |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2010 | $843,336 | training reimbursement | |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2002 | $828,938 | enterprise zone | |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2014 | $822,257 | property tax abatement | |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $816,254 | tax credit/rebate | |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 1998 | $815,500 | tax credit/rebate | |
Novartis | Novartis | New Jersey | state | 2005 | $810,000 | tax credit/rebate | |
Aventis Pasteur Inc. | Sanofi | Pennsylvania | state | $810,000 | tax credit/rebate | ||
Pfizer, Inc. | Pfizer | North Carolina | state | 2019 | $802,663 | tax credit/rebate | |
Wyeth | Pfizer | Pennsylvania | state | 2008 | $802,021 | tax credit/rebate | |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2014 | $800,000 | tax credit/rebate | |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2021 | $795,000 | tax credit/rebate | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $794,527 | enterprise zone | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $794,527 | enterprise zone | |
MedImmune LLC | AstraZeneca | Maryland | state | 2021 | $794,270 | tax credit/rebate | |
MedImmune, LLC | AstraZeneca | Maryland | state | 2020 | $791,333 | tax credit/rebate | |
Spark Therapeutics, LLC | Roche | Pennsylvania | state | 2017 | $790,740 | tax credit/rebate | |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2010 | $790,040 | tax credit/rebate; property tax abatement | |
Zoetis, LLC | Zoetis | Nebraska | state | 2022 | $789,317 | tax rebate | |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2020 | $788,701 | tax credit/rebate | |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2013 | $784,000 | tax credit/rebate | |
Ultragenyx Pharmaceutical | Ultragenyx Pharmaceutical | Massachusetts | state | 2020 | $780,952 | tax credit/rebate | |
Amgen Inc. | Amgen | Massachusetts | state | 2016 | $780,000 | tax credit/rebate | |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $770,277 | tax credit/rebate | |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2015 | $765,357 | tax credit/rebate | |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2014 | $764,142 | enterprise zone | |
Pfizer, Inc. | Pfizer | North Carolina | state | 2013 | $755,362 | tax credit/rebate | |
MALLINCKRODT MEDICAL, INC. | Mallinckrodt | Missouri | state | 2000 | $754,909 | tax credit/rebate | |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | enterprise zone | |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | enterprise zone | |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | enterprise zone | |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $751,067 | tax credit/rebate | |
Novartis | Novartis | New Jersey | state | 2005 | $750,000 | tax credit/rebate | |
Endo Pharmaceuticals | Endo International | Pennsylvania | state | $750,000 | grant | ||
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $750,000 | tax credit/rebate | |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2009 | $750,000 | grant | |
EMERGENT BIOSOLUTIONS INC | Emergent BioSolutions | Maryland | local | 2014 | $750,000 | grant/loan hybrid program | |
Abiomed Inc | Johnson & Johnson | Massachusetts | state | 2017 | $750,000 | tax credit/rebate | |
Abiomed, Inc. | Johnson & Johnson | Massachusetts | state | 2018 | $750,000 | tax credit/rebate | |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2015 | $749,365 | property tax abatement | |
Novo Nordisk Pharmaceuticals | Novo Holdings A/S | North Carolina | state | 2008 | $746,648 | tax credit/rebate | |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2011 | $743,297 | tax credit/rebate | |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2011 | $740,939 | tax credit/rebate | |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2014 | $740,512 | training reimbursement | |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $740,231 | tax credit/rebate | |
Merck & Co., Inc. | Merck | Pennsylvania | state | $735,000 | training reimbursement | ||
GlaxoSmithKline | GlaxoSmithKline | United States | federal | 2012 | $729,692 | federal grant | |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2005 | $728,623 | tax credit/rebate | |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2017 | $726,780 | tax credit/rebate | |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2019 | $723,229 | tax credit/rebate | |
Janssen Biotech, Inc. | Johnson & Johnson | Pennsylvania | state | 2017 | $720,954 | tax credit/rebate | |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $718,878 | tax credit/rebate | |
Regeneron - 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2015 | $715,196 | tax credit/rebate | |
Aegerion Pharmaceuticals | Amryt Pharma | Massachusetts | state | 2014 | $715,085 | tax credit/rebate | |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2015 | $709,291 | tax credit/rebate | |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2015 | $708,343 | tax credit/rebate | |
Doral Arrowwood (Pfizer) | Pfizer | New York | local | 2005 | $701,075 | tax credit/rebate; property tax abatement | |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | $699,000 | tax credit/rebate | ||
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | enterprise zone | |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | enterprise zone | |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | enterprise zone | |
Medimmune, LLC | AstraZeneca | Maryland | state | 2010 | $698,034 | tax credit/rebate | |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $695,000 | grant | |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2017 | $693,503 | tax credit/rebate | |
Actavis, Inc. | AbbVie | Florida | state | 2013 | $690,000 | grant | |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $687,362 | tax credit/rebate | |
Perceptive Services, Inc. | Parexel International | New Jersey | state | 2005 | $685,125 | grant | |
Elanco Us Inc. | Elanco Animal Health | Iowa | state | 2015 | $684,174 | training reimbursement | |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2005 | $680,000 | enterprise zone | |
Eisai, Inc. | Eisai | New Jersey | state | 2005 | $677,820 | Tax credit/rebate | |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2017 | $677,616 | tax credit/rebate | |
Abiomed Inc. | Johnson & Johnson | Massachusetts | state | 2021 | $675,000 | tax credit/rebate | |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2016 | $671,544 | tax credit/rebate | |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2008 | $668,300 | tax credit/rebate | |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2015 | $666,542 | tax credit/rebate | |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2016 | $666,448 | tax credit/rebate | |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2012 | $666,023 | tax credit/rebate; property tax abatement | |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2016 | $664,984 | tax credit/rebate | |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $662,500 | enterprise zone | |
Doral/Pfizer | Pfizer | New York | local | 2007 | $662,163 | tax credit/rebate; property tax abatement | |
Regeneron Pharmaceuticals III | Regeneron Pharmaceuticals | New York | local | 2019 | $660,340 | tax credit/rebate | |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2015 | $657,567 | tax credit/rebate | |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2013 | $656,436 | tax credit/rebate | |
Regeneron Pharmacueticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2004 | $653,700 | enterprise zone | |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $653,000 | grant |